Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
35.19
-2.16 (-5.78%)
Mar 31, 2025, 10:09 AM EDT - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $6.54 billion as of March 31, 2025. Its market cap has increased by 19.47% in one year.
Market Cap
6.54B
Enterprise Value
4.79B
1-Year Change
19.47%
Ranking
Category
Stock Price
$35.19
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $6.54B, an increase of 297.83%. That is a compound annual growth rate of 30.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 6.94B | -14.09% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |